Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort

Treatment guidelines differ in their recommendation to determine baseline resistance associated substitutions (RAS) before starting a first-line treatment with direct-acting antivirals (DAAs). Here we analyze the efficacy of DAA treatment with baseline RAS information. We conducted a prospective stu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Pérez, Ana Belén, Chueca, Natalia, Macías, Juan, Pineda, Juan Antonio, Salmerón, Javier, Rivero-Juárez, Antonio, Hidalgo-Tenorio, Carmen, Espinosa, María Dolores, Téllez, Francisco, Von-Wichmann, Miguel Ángel, Omar, Mohamed, Santos, Jesús, Hernández-Quero, José, Antón, José Joaquin, Collado, Antonio, Lozano, Ana Belén, García-Deltoro, Miguel, Casado, Marta, Pascasio, Juan Manuel, Selfa, Aida, Rosales, José Miguel, De la Iglesia, Alberto, Arenas, Juan Ignacio, García-Bujalance, Silvia, Ríos, María José, Bernal, Enrique, Martínez, Onofre, García-Herola, Antonio, Vélez, Mónica, Rincón, Pilar, García, Federico
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716636/
https://ncbi.nlm.nih.gov/pubmed/31469856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0221231
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia